GlaxoSmithKline (GB:GSK) has released an update. GSK has announced promising new data for its RSV vaccine, Arexvy, which ...

The firm says staff were told about the potential job losses and site's closure on Monday ... not sweeten its bid for the healthcare arm of GlaxoSmithKline. The maker of Marmite and PG Tips ...

Bernstein analyst Justin Smith maintained a Buy rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of ...

The FDA has approved use of GlaxoSmithKline’s Boostrix (Tdap ... according to GSK’s chief vaccine official, Dr Peter Marks. Pertussis is a highly contagious respiratory disease that can ...

At GlaxoSmithKline, we never lose sight of the fact that patients are at the core of what we do and that millions of lives are impacted by cancer. The patient’s voice is at the heart of our ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Revenue from operations rose to Rs 1,010 crore for the September quarter compared with Rs 957 crore in the year-ago period, ...

In a report released today, Jo Walton from UBS maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target ...

The US Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups.

Commissions do not affect our editors' opinions or evaluations. Thanks to website builders, it’s easier than ever to create your own website without having any coding knowledge. Website builders ...

What was Glaxosmithkline Pharmaceuticals Ltd share ... historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Melanie Pinola Melanie Pinola is a writer focused on home-office gear.